Johnson & Johnson (NYSE:JNJ) is a name I've been bearish on for some time. This stock was caught up in the dividend stock feeding frenzy that has engulfed the US market over the last couple of years as yield-starved investors bought high-quality names like JNJ at a feverish pace. But since the stock topped out at $125 earlier this year, it has been trading down and that continued after a disappointing Q3 report as shares are now at $114. But with support for the stock looming, is JNJ a buy here?
